OP04 Safety and efficacy of the terminal complement inhibitor eculizumab in patients with paroxysmal nocturnal hemoglobinuria: Shepherd Phase III clinical study results
Titel:
OP04 Safety and efficacy of the terminal complement inhibitor eculizumab in patients with paroxysmal nocturnal hemoglobinuria: Shepherd Phase III clinical study results
Auteur:
Muus, P. Luzzatto, L. Rotoli, B. Young, N.S. Schubert, J. Urbano-Ispizua, A. Coyle, L. DeCastro, C. Fu, C.L. Maciejewski, J.P. Kroon, H.A. Rother, R.P. Hillmen, P. Schrezenmeier, H.